Open access peer-reviewed chapter

MCF-7 Breast Cancer Cell Line, a Model for the Study of the Association Between Inflammation and ABCG2-Mediated Multi Drug Resistance

By Fatemeh Kalalinia, Fatemeh Mosaffa and Javad Behravan

Submitted: December 6th 2010Reviewed: May 1st 2011Published: December 14th 2011

DOI: 10.5772/24370

Downloaded: 3752

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Fatemeh Kalalinia, Fatemeh Mosaffa and Javad Behravan (December 14th 2011). MCF-7 Breast Cancer Cell Line, a Model for the Study of the Association Between Inflammation and ABCG2-Mediated Multi Drug Resistance, Breast Cancer - Focusing Tumor Microenvironment, Stem cells and Metastasis, Mehmet Gunduz and Esra Gunduz, IntechOpen, DOI: 10.5772/24370. Available from:

chapter statistics

3752total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Interaction of Alkylphospholipid Formulations with Breast Cancer Cells in the Context of Anticancer Drug Development

By Tilen Koklic, Rok Podlipec, Janez Mravljak, Marjeta Šentjurc and Reiner Zeisig

Related Book

First chapter

EGFR-Ligand Signaling in Breast Cancer Metastasis: Recurring Developmental Themes

By Nicole K. Nickerson, Jennifer L. Gilmore, Kah Tan Allen, David J. Riese II, Kenneth P. Nephew and John Foley

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us